Rights and permissions
About this article
Cite this article
Rotavirus vax should be “highly cost-effective” in Bolivia. Pharmacoecon. Outcomes News 632, 5 (2011). https://doi.org/10.2165/00151234-201106320-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201106320-00010